Moderna says FDA reversing course, will review mRNA flu shot
Moderna says FDA reversing course, will review mRNA flu shot | 18 Feb 2026 | Moderna said Wednesday that the Food and Drug Administration is reversing course, and will now review the company's mRNA flu shot. The reversal comes after Moderna said last week that the FDA's Center for Biologics…